Much higher risk of premalignant and malignant cervical diseases in younger women positive for HPV16 than in older women positive for HPV16

Citation
H. Tanaka et al., Much higher risk of premalignant and malignant cervical diseases in younger women positive for HPV16 than in older women positive for HPV16, MICROB IMMU, 45(4), 2001, pp. 323-326
Citations number
18
Categorie Soggetti
Microbiology
Journal title
MICROBIOLOGY AND IMMUNOLOGY
ISSN journal
03855600 → ACNP
Volume
45
Issue
4
Year of publication
2001
Pages
323 - 326
Database
ISI
SICI code
0385-5600(2001)45:4<323:MHROPA>2.0.ZU;2-6
Abstract
Human papillomavirus (HPV), particularly HPV16, is strongly associated with premalignant lesions of the uterine cerris and cervical cancer. However HP V infection is a common sexually transmitted disease and only a few women d evelop cervical cancer. Although the presence of HPV and abnormal cytology are independent risk factors for cervical diseases, implementing both tests on every woman is argued not to be recommended mainly in terms of cost-eff ectiveness. During a 20-month period between October, 1994, and May, 1996, cervical swabs from 207 women who were referred for colposcopy because of c ervical dyskaryosis (Papanicolaou class IIIa or higher) were examined by PC R for the presence of HPV16. when these women were divided into two groups; i.e., group A consisting of women who were 44 years old or younger (n = 11 1), and group B consisting of women who were 45 years old or older (n = 96) , the risk of having premalignant and malignant cervical diseases upon infe ction with HPV16 was approximately 8 times higher in group A than in group B. Thus, we conclude that HPV-testing should be implemented on every young woman with an abnormal Papanicolaou smear test.